These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 2169543)
1. [Advances in research of malignant hyperthermia]. Takagi A; Kojima S Nihon Rinsho; 1990 Jul; 48(7):1557-62. PubMed ID: 2169543 [No Abstract] [Full Text] [Related]
2. Malignant hyperthermia may be due to a defect in a large Ca2+ release channel protein. Davies K Trends Genet; 1990 Jun; 6(6):171-2. PubMed ID: 2164719 [No Abstract] [Full Text] [Related]
4. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle]. Monnier N; Lunardi J Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701 [TBL] [Abstract][Full Text] [Related]
5. [Physiology and fine structure of skeletal muscle--triad junction]. Nonomura Y Nihon Rinsho; 1990 Jul; 48(7):1365-71. PubMed ID: 2169538 [No Abstract] [Full Text] [Related]
6. Control of calcium in skeletal muscle excitation-contraction coupling: implications for malignant hyperthermia. Wingertzahn MA; Ochs RS Mol Genet Metab; 1998 Oct; 65(2):113-20. PubMed ID: 9787103 [TBL] [Abstract][Full Text] [Related]
7. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Zucchi R; Ronca-Testoni S Pharmacol Rev; 1997 Mar; 49(1):1-51. PubMed ID: 9085308 [No Abstract] [Full Text] [Related]
11. [Control mechanism of intracellular calcium in skeletal muscle]. Kirino Y Nihon Rinsho; 1990 Jul; 48(7):1401-8. PubMed ID: 2169541 [No Abstract] [Full Text] [Related]
12. Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease. Lyfenko AD; Goonasekera SA; Dirksen RT Biochem Biophys Res Commun; 2004 Oct; 322(4):1256-66. PubMed ID: 15336973 [TBL] [Abstract][Full Text] [Related]
13. No C1840 to T mutation in RYR1 in malignant hyperthermia. Hall-Curran JL; Stewart AD; Ball SP; Halsall JP; Hopkins PM; Ellis FR Hum Mutat; 1993; 2(4):330. PubMed ID: 8401544 [No Abstract] [Full Text] [Related]
14. [Mutations in the gene responsible for malignant hyperthermia]. Fujii J; Otsu K Seikagaku; 1992 Sep; 64(9):1129-33. PubMed ID: 1460346 [No Abstract] [Full Text] [Related]
15. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. MacLennan DH; Duff C; Zorzato F; Fujii J; Phillips M; Korneluk RG; Frodis W; Britt BA; Worton RG Nature; 1990 Feb; 343(6258):559-61. PubMed ID: 1967823 [TBL] [Abstract][Full Text] [Related]
16. Calcium channels expressed in vascular smooth muscle. Marks AR Circulation; 1992 Dec; 86(6 Suppl):III61-7. PubMed ID: 1330365 [TBL] [Abstract][Full Text] [Related]
17. Analysis of expression of the human ryanodine receptor gene in malignant hyperthermia skeletal muscle tissue. Gillian CM; Heffron JJ; Lehane M; Marks A; McCarthy TV Biochem Soc Trans; 1991 Feb; 19(1):46S. PubMed ID: 1709891 [No Abstract] [Full Text] [Related]
18. Genomic organization of the porcine skeletal muscle ryanodine receptor (RYR1) gene coding region 4624 to 7929. Leeb T; Schmölzl S; Brem G; Brenig B Genomics; 1993 Nov; 18(2):349-54. PubMed ID: 8288238 [TBL] [Abstract][Full Text] [Related]
19. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary]. Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536 [TBL] [Abstract][Full Text] [Related]
20. Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia. Manning BM; Quane KA; Lynch PJ; Urwyler A; Tegazzin V; Krivosic-Horber R; Censier K; Comi G; Adnet P; Wolz W; Lunardi J; Muller CR; McCarthy TV Hum Mutat; 1998; 11(1):45-50. PubMed ID: 9450902 [No Abstract] [Full Text] [Related] [Next] [New Search]